Cargando…

Impact of donor age on liver transplant outcomes in patients with hepatocellular carcinoma: analysis of the SRTR database

BACKGROUND: Donor age is an important predictor for liver transplant recipients. Studies have not fully explored its impact on transplant outcomes in hepatocellular carcinoma (HCC) patients as well as its involvement in tumor recurrence. METHODS: HCC patients who received liver transplants during 20...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Jie, Huang, Zhichao, Chen, Zheng, Xu, Fangshen, Tong, Rongliang, Zheng, Shusen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086097/ https://www.ncbi.nlm.nih.gov/pubmed/33931011 http://dx.doi.org/10.1186/s12876-021-01786-6

Ejemplares similares

Outcomes of Combined Liver and Pancreas Transplantation: A Review of the SRTR National Database and a Report of the Largest Single Center Series
por: Li, Cheukfai, et al.
Publicado: (2020)

Outcomes of liver–kidney transplantation in patients with primary hyperoxaluria: an analysis of the scientific registry of transplant recipients database
por: Xiang, Jie, et al.
Publicado: (2020)

OPTN/SRTR 2021 Annual Data Report: Lung
por: Valapour, Maryam, et al.
Publicado: (2023)

OPTN/SRTR 2021 Annual Data Report: Kidney
por: Lentine, Krista L., et al.
Publicado: (2023)

BAG3 and HIF-1α Coexpression Detected by Immunohistochemistry Correlated with Prognosis in Hepatocellular Carcinoma after Liver Transplantation
por: Xiao, Heng, et al.
Publicado: (2014)

A case report of de novo hepatocellular carcinoma after living donor liver transplantation
por: Yu, Songfeng, et al.
Publicado: (2013)

OPTN/SRTR 2021 Annual Data Report: COVID-19
por: Miller, Jonathan M., et al.
Publicado: (2023)

Lung Transplant Outcomes in Adults in the United States: Retrospective Cohort Study Using Real-world Evidence from the SRTR
por: Erdman, Jay, et al.
Publicado: (2022)

Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016
por: Golabi, Pegah, et al.
Publicado: (2018)

Systematic Assessment of Safety Threshold for Donor Age in Cadaveric Liver Transplantation
por: Wang, Wenchao, et al.
Publicado: (2021)

Living Donor Liver Transplantation for Hepatocellular Carcinoma: It Is All about Donors?
por: Saidi, R. F., et al.
Publicado: (2013)

The Matching Status Between Donor and Recipient Hepatitis B Seroepidemiology Makes a Difference in Liver Transplantation for Hepatocellular Carcinoma
por: Lu, Di, et al.
Publicado: (2020)

Living Donor Liver Transplantation for Patients with Hepatocellular Carcinoma
por: Akamatsu, Nobuhisa, et al.
Publicado: (2014)

Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma after Liver Resection: Retrospective Study of the Milan and Hangzhou Criteria
por: Hu, Zhenhua, et al.
Publicado: (2014)

Prediction of Early Recurrence of Hepatocellular Carcinoma in Patients with Cirrhosis Who Had Received Deceased Donor Liver Transplantation: A Multicenter Study
por: Al-Ameri, Abdulahad Abdulrab Mohammed, et al.
Publicado: (2019)

Liver Grafts for Transplantation from Donors with Diabetes: An Analysis of the Scientific Registry of Transplant Recipients Database
por: Zheng, Jun, et al.
Publicado: (2014)

Can living donor liver transplantation offer similar outcomes to deceased donor liver transplantation using expanded selection criteria for hepatocellular carcinoma?
por: Chen, Li-Ping, et al.
Publicado: (2015)

Outcomes of Living Donor Liver Transplantation in Patients With a History of Ruptured Hepatocellular Carcinoma
por: Lee, Hwi Yeol, et al.
Publicado: (2021)

The Stratifying Value of Hangzhou Criteria in Liver Transplantation for Hepatocellular Carcinoma
por: Chen, Jun, et al.
Publicado: (2014)

The XRE Family Transcriptional Regulator SrtR in Streptococcus suis Is Involved in Oxidant Tolerance and Virulence
por: Hu, Yuli, et al.
Publicado: (2019)

Can living donor liver transplantation provide similar outcomes to deceased-donor liver transplantation for hepatocellular carcinoma? A systematic review and meta-analysis
por: Elkomos, Beshoy Effat, et al.
Publicado: (2022)

Salvage Liver Transplantation Is a Reasonable Option for Selected Patients Who Have Recurrent Hepatocellular Carcinoma after Liver Resection
por: Hu, Zhenhua, et al.
Publicado: (2012)

Advances and Challenges in Cytomegalovirus Detection Methods for Liver Transplant Donors
por: Li, Xiaoping, et al.
Publicado: (2023)

The predictive value of the modified AFP model for liver transplantation outcomes in multinodular hepatocellular carcinoma patients
por: Wang, Jingrui, et al.
Publicado: (2023)

Predictive value of pre-transplant platelet to lymphocyte ratio for hepatocellular carcinoma recurrence after liver transplantation
por: Xia, Weiliang, et al.
Publicado: (2015)

Preoperative risk stratification for early recurrence of HBV-related hepatocellular carcinoma after deceased donor liver transplantation: a five-eight model development and validation
por: Al-Ameri, Abdulahad Abdulrab Mohammed, et al.
Publicado: (2019)

A model integrating donor gene polymorphisms predicts fibrosis after liver transplantation
por: Wang, Chao, et al.
Publicado: (2020)

Clinical practice guideline on liver transplantation for hepatocellular carcinoma in China (2021 edition)
por: Chen, Jun, et al.
Publicado: (2022)

Liver transplantation for hepatocellular carcinoma beyond the Milan criteria
por: Xu, Xiao, et al.
Publicado: (2016)

Spectrum of De Novo Cancers and Predictors in Liver Transplantation: Analysis of the Scientific Registry of Transplant Recipients Database
por: Zhou, Jie, et al.
Publicado: (2016)

When to call it off: defining transplant candidacy limits in liver donor liver transplantation for hepatocellular carcinoma
por: Bhatti, Abu Bakar Hafeez, et al.
Publicado: (2020)

Predictor of outcome after living donor liver transplantation for patients with hepatocellular carcinoma beyond the Japan criteria
por: Yonemura, Yusuke, et al.
Publicado: (2020)

Outcomes associated with the intention of loco-regional therapy prior to living donor liver transplantation for hepatocellular carcinoma
por: Wu, Tsung-Han, et al.
Publicado: (2020)

Repeated-Measures Implication of Hepatocellular Carcinoma Biomarkers in Living Donor Liver Transplantation
por: Chiu, King-Wah, et al.
Publicado: (2015)

De-novo hepatocellular carcinoma after pediatric living donor liver transplantation
por: Torres-Landa, Samuel, et al.
Publicado: (2017)

Recurrence of hepatocellular carcinoma following deceased donor liver transplantation: case series
por: Simsek, Cem, et al.
Publicado: (2020)

Living donor liver transplantation for advanced hepatocellular carcinoma including macrovascular invasion
por: Bhatti, Abu Bakar Hafeez, et al.
Publicado: (2021)

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation
por: Lee, Okjoo, et al.
Publicado: (2022)

Donor sex and donor-recipient sex disparity do not affect hepatocellular carcinoma recurrence after living donor liver transplantation
por: Oh, Rak Kyun, et al.
Publicado: (2023)

MicroRNA-424 expression predicts tumor recurrence in patients with hepatocellular carcinoma following liver transplantation
por: Wu, Liming, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bfj3b97cfs58lt5rfhhkp9oeq2